Urinary neutral endopeptidase 24.11 activity: Modulation by chronic salt loading. Neutral endopeptidase (NEP) 24.11 is a zinc-metallopeptidase involved in the metabolism of several biologically active peptides including enkephalin, atrial natriuretic peptide, bradykinin, and endothelin. The enzyme is found in abundant amounts in the brush border of renal proximal epithelial cells. A soluble form of NEP was previously identified in human urine with characteristics similar to the renal enzyme. The present study further characterized the excreted form of NEP activity in urine of normal rats using a sensitive two-stage enzymatic assay. The response of urinary NEP to known inhibitors such as phosphoramidon and thiorphan, and its dependence on pH and salt concentration was studied. In addition, we evaluated the effects of acute and chronic changes in salt balance, induced by i.v. saline infusion and drinking of saline solution, on urinary NEP and on the activity of the enzyme in isolated proximal tubules. Our findings demonstrated that abundant NEP activity was detected in the urine of normal rats. Furthermore, chronic salt loading, but not acute salt infusion, was associated with increased activity of NEP in urine and in isolated proximal tubules, suggesting that the enzyme may be regulated by salt balance. Finally, the data suggest that urinary NEP may be used as an index of enzyme activity in the kidney.
blockers is associated with increased urinary excretion of ANP and its second messenger cyclic guanosine monophosphate, natriuresis, and prolongation of the half-life of ANP [ii, 12] . Similarly, the excretion of endothelin in the urine and that of bradykinin are also increased following NIEP inhibition [4, 13] . These peptides participate in the regulation of renal hemodynamics and urinary sodium excretion, either as circulating hormones or in a paracrine mode of action. The involvement of this enzyme in the degradation of the natriuretic peptide family [14] has led to the hypothesis that alterations in the endogenous renal NEP activity may exist in situations associated with deranged sodium homeostasis such as congestive heart failure [15, 16] . However, direct measurements of renal NEP activity to support the latter possibility are not available. Moreover, it is not known at present whether the activity of the enzyme in the kidney is influenced by sodium balance under normal physiological conditions.
An excreted form of NEP was previously identified in human urine by Skidgel et al [17] . The urinary enzyme appears to be of a molecular size similar to the renal enzyme. Furthermore, both the purified renal NEP and the urinary enzyme were inhibited to the same extent by phosphoramidon and thiorphan, and the activity of the urinary enzyme was inhibited by specific antiserum against the renal NEP [17] . These findings suggest that urinary enzyme is of renal origin and, therefore, that urinary NEP might reflect the activity of the enzyme in the kidney. The latter assumption is also supported by the following reasoning: First, NEP is an ectoenzyme, that is, it is present on the surface of the epithelial tubular cells and therefore may appear in the urine like other peptides of tubular origin. Moreover, data are now available to indicate that a major portion of the enzyme (93% of the total amino acid sequence), including the active site, is present in the extracellular domain [18, 19] . Second, because of its large size, 94 kilodaltons, the enzyme is apparently not filtered by the glomerulus, suggesting that urinary NEP is largely of renal origin. Finally, NEP is a relatively stable protein which resists significant proteolytic action, which might explain why the excreted enzyme remains active in urine.
Thus, the present study was undertaken with two main objectives: (1) to characterize the activity of NEP in the urine of normal rats and to define standard assay conditions for its measurement, and (2) to evaluate the effects of acute and chronic alterations in sodium intake on renal and urinary NEP activity.
The data to be presented indicate that NEP is found in 855 abundant amounts in the urine. Moreover, our findings further indicate that the activity of the enzyme in the kidney and the urine may be modulated by chronic alterations in sodium intake. Methods Studies were conducted on a local strain of male Wistar rats (200 to 250 g) maintained on a standard rat chow (0.6% NaC1) and tap water ad libitum. The animals were placed in individual metabolic cages for daily monitoring of urine output and sodium excretion. Urine was collected on a 24 hour basis, aliquots were used for measurements of sodium concentration, and the rest was frozen and stored at -70°C for determination of NEP activity.
Experimental protocols
To evaluate the effect of alterations in sodium intake on urinary NEP activity, two experimental maneuvers were undertaken. A group of 14 animals were placed in individual metabolic cages, and urine was collected for five days (baseline period). On the sixth day the drinking water was replaced by normal saline (0.9% NaC1) for five additional days (days 6 to 10). On the eleventh day five animals were anesthetized by i.p. injection of sodium pentobarbital (40 mg/kg), their kidneys were removed through a midline incision, and proximal tubules were isolated (see below).
In the remaining nine rats, saline was replaced by tap water for another five days (recovery period, days 11 to 16). An additional group (N = 5) was maintained on tap water throughout the experiment and served as a time control. Four additional control animals were sacrificed on the eleventh day, and suspensions of isolated proximal tubules were prepared from their renal cortices.
Acute studies
Six Wistar rats (250 to 300 g) were anesthetized by i.p. injection of 5-sec-butyl-5-ethyl-2 thiobarbituric acid (100 mg/kg, mactin, Byk, Guldens, Germany) and prepared for clearance studies.
Following tracheostomy, the carotid artery and jugular vein were cannulated by polyethylene tubing, PE50, for recording of mean arterial pressure, blood sampling, and infusion of various solutions. The urinary bladder was catheterized via a suprapubic incision for urine collection. A solution containing 2% inulin in normal saline was infused throughout the experiment at a rate of 1.5 ml/hr. The total volume of saline administered was adjusted by another syringe pump to equal 1% of body weight. After a one-hour equilibration period, a 30-minute baseline clearance collection was obtained. The rate of saline infusion was then increased to equal 5% of body weight administered in 20 minutes.
Four additional clearance periods of 20 minutes each were obtained in the volume expansion state. Urine flow was matched by an equivalent i.v. infusion of saline. Blood samples (0.3 ml) were obtained at the midpoint of each clearance period. Blood and urine samples were analyzed for inulin and sodium concentrations. Urine aliquots were frozen and kept at -70°C until assayed for NEP activity.
Preparation of isolated proximal nephrons Suspensions of isolated proximal tubules were prepared according to the method of Vinay, Gougoux and Lemieux [20] with slight modifications. Following anesthesia with sodium pentobarbital, the kidneys were rapidly removed and placed in ice-cold KrebsHenseleit saline (KHS) of the following composition (in mM):
NaCl 140, KCI 3, NaH2PO4 1, MgC12 1, CaCI2 1, glucose 5 (pH 7.4). After decapsulation the cortices were dissected, placed in KI-IS (10 mug tissues), and minced with a razor blade. The minced tissue was transferred into 10 ml 1(1-IS containing 0.8 mg/mI Type I collagenase (Clostridium histolyticum, Sigma, St. Louis, MO, USA) and 5 mg/mI bovine serum albumin (Fraction V, Sigma) and incubated for one hour at 37°C. The mixture was then centrifuged for one minute at 300 rpm, and the supernates were discarded twice. The tubules were then incubated in the cold with bovine serum albumin (0.5 g/ml) for 10 minutes, pelleted, and resuspended in 40 ml ice-cold 2X concentrated KHS:Percoll mixture (1:1, 14 mOsm/kg; Pharmacia LKB, Uppsala, Sweden) previously gassed with 95% 02 -5% CO2 for 30 minutes. The Percoll solution was centrifuged at 12,000 g for 30 minutes at 4°C.
The lowermost band, containing fragments of proximal tubules, was collected and resuspended in Percoll solution diluted with 1(1-IS (1:2 to 1:3). The purity of the suspension, as evaluated by microscopic inspection, was >95%. Tubules were pelleted by microcentrifuge and stored at -20°C.
Determination of NEP 24.11 activity The activity of NEP in urine samples and in isolated proximal tubular suspensions was assayed with a sensitive two-stage enzymatic reaction [21] using the substrate 3-carboxypropranoylalanyl-alanyl-Ieucine-4 nitroanilide supplemented with bacterial (Streptomyces griseus) aminopeptidase I (SGAPI). The substrate is initially attacked at the alanyl-leucine bond by NEP 24.11, making the leucine-4-nitroanilide moiety available to SGAPI, with a concomitant increase of absorption at 405 nm due to the release of 4-nitroaniline (E405 = 10,600 M 1cm 1)• This assay is able to detect femtomolar concentrations of NEP [21] .
Urine samples (4 to 5 11) or aliquots of tubular suspensions (containing 10 to 20 g protein) were micropipetted and placed in a 96-well microtiter plate with 200 tl of Buffer A (100 mri NaCI, 10 mM CaCI2, 50 mrvi Tris titrated to pH 7.91 with HCI, 0.4 mM substrate, and 6.5 igIml SGAPI) heated to 37°C. Reactions were carried out in a thermoregulated automated microplate reader (Ceres 900, Biotek Instruments, Winooski, VT, USA) for 25 to 30 minutes after a five-minute preincubation period. Under these conditions, linear plots of the absorbance changes were recorded, allowing for a maximal reaction rate of 10 mOD/mm. The activity of NEP in urine was normalized to urinary creatinine concentration and expressed as mOD min1 j.g' creatinine. In the clearance experiments the enzyme activity in urine was normalized per milligram inulin. NEP activity in tubular suspensions was expressed per ig of protein as determined by the Lowry method [22] adapted to microsamples.
Enzyme activity may vary upon changes in temperature, pH, and ionic strength of the medium. In the present study NEP activity was determined at 37°C unless otherwise specified. Moreover, to account for the possible large variations in urinary pH and ionic strength, standard assay conditions were chosen based upon preliminary experiments in which the effects of changes in pH (range, 5.6 to 9.2) and sodium concentrations (0.1 to 2.0 M) on urinary NEP activity were studied. In an additional set of experiments the inhibitory effects of known blockers of NEP 24.11, phosphoramidon (Peninsula Laboratories, Belmont, CA, USA) and thiorphan (Sigma) were studied on enzyme activity in the urine. 
Results
Assay conditions The effects of variations in the pH and salt concentration of the assay medium on urinary NEP activity are shown in Figure 1 . At 37°C the activity was maximal at a pH of 7.91, with a sharp decline at higher or lower pH values.
The increase in salt concentration of the assay medium also markedly affected urinary NEP activity in a non-linear, hyperbolic fashion. The increase was more rapid in the low physiological range and slower at higher salt concentrations. Thus, in the present study a pH of 7.91 and concentration of 100 mvi NaC1
were chosen as a standard assay for determination of NEP activity.
Effect of inhibitors
The effects of incremental concentrations (10_h to i03 M) of phosphoramidon and thiorphan on urinary NEP activity are demonstrated in Figure 2 . In this set of experiments the assay conditions were changed (pH 7.5, temperature 26°C) in order to duplicate the specific assay conditions used in the original publication [21] . A typical sigmoidal dose-response curve was obtained that was of similar magnitude for both inhibitors (Fig. 2) . The calculated K1 values for phosphoramidon and for thiorphan were 1.23 0.8 and 0.87 0.1 nm, respectively. Figure 3 depicts the average daily urinary sodium excretion rate and urinary NEP activity during baseline (Days 1 to 5), high salt intake (Days 6 to 10), and recovery (Days 11 to 16). Changing the drinking water from tap water to 0.9% saline resulted in an abrupt increase in daily sodium excretion, with a fourfold maximal increase in absolute rate of daily sodium excretion (Fig. 3) .
Effects of high salt intake
Concomitant with the increase in urinary sodium excretion, NEP Fig. 1 . Effects of variations in pH (A) and salt concentration (B) in assay media on urina,y NEP activity. Data on pH effects are based on seven urine samples assayed at 37°C and a 100 mM NaCI concentration. The line representing the changes in enzyme activity due to variations in NaCI concentration was generated by a sigmoidal curve fitting procedure based on data from seven different urine samples assayed at pH 7.91. activity in the urine increased in a time course and magnitude similar to the change in sodium excretion. The maximal increase in urinary NEP activity was observed on the second day of salt loading, slightly preceding the peak natriuretic response (Fig. 3) , and remained elevated throughout the period of salt loading.
Urinary NEP activity increased both when expressed in absolute terms (mOD/24 hr; data not shown) as well as when corrected for urinary creatinine concentration to account for changes in urine dilution and increased flow (Fig. 3) . These changes in urinary sodium and NEP activity returned to normal baseline values in the recovery phase upon cessation of saline loading. In the control group, maintained on tap water, urinary NEP activity remained constant throughout the experiment.
Data on NEP activity in suspensions of isolated proximal tubules from rats with normal (N = 4) and high salt intake, given for five days, (N = 4) are shown in Figure 4 . NEP activity was significantly higher in proximal tubules derived from kidneys of rats with high salt intake than in normal controls (441.5 43.4 vs. 244.4 24.7 mOD min1 mg' protein; P < 0.05). Thus, the istration of saline. Yet, in contrast to the chronic increase in increase in urinary NEP activity following high salt intake was also sodium intake, acute saline expansion was not associated with any reflected by similar alterations in enzyme activity in the proximal measurable increase in urinary NEP activity (Table 1) . nephron. Discussion Effects of acute saline expansion on urinary NEP
The present study provides important and novel information
The effects of acute volume expansion by saline infusion on regarding the activity of NEP in the kidney and urine. Our renal function and NEP activity in urine are summarized in Table findings indicate that NEP is present in significant amounts not 1. Infusion of 0.9% saline solution in an amount equivalent to 5% only in renal tissue, but also in the urine. Secondly, the activity of of body weight resulted in a significant diuretic and natriuretic the enzyme in the urine displays characteristics similar to those response, with no change in GFR or mean arterial BP. The reported in the kidney and other tissues in terms of susceptibility increments in sodium excretion were of a magnitude (four-to to known inhibitors [21, 23] and pH regulation [24] . Finally, and fivefold increase) similar to that observed during the oral admin-most important, the activity of NEP in urine and in isolated proximal tubules appears to be modulated by chronic salt loading, but not by acute saline infusion. The latter finding suggests that renal activity of NEP may be up-regulated as part of the adaptive response to increased dietary salt intake. Although the kidney is among the richest sources of NEP in the body, the possibility that the enzyme may be secreted into the urine has not gained much interest, nor has the contention that urinary NEP may reflect the activity of the enzyme in the kidney. The existing data in the literature regarding the activity of NEP in the urine are scant and incomplete [17, 25] . As pointed out earlier, the presence of NEP activity in human urine, with characteristics similar to the renal enzyme, was previously reported by Skidgel et al [17] . More recently it has been shown that urinary NEP activity may be altered in the early days following kidney transplantation [26] . However, whether the latter finding has any pathophysiological significance is unknown at present. For reasons outlined earlier, we speculated that urinary NEP must be primarily of renal origin. Therefore, it is logical to assume that alterations in renal NEP activity should be reflected in the final urine. Yet the possibility that other sources, in addition to the kidney, may contribute to NEP activity in the urine must also be considered. Thus, it is currently not known whether NEP is present in or may be secreted from epithelial cells of the lower urinary tract. A high content of NEP is found in the prostate and epididymis [27] , which may be another important source of urinary NEP in the male rat. However, the observation that NEP activity in the urine markedly increased following chronic salt loading is highly suggestive of a renal rather than non-renal origin of the enzyme. Taken together, arguments supporting the renal origin of the urinary enzyme and the effect of salt loading on urinary and renal NEP activity provide the rationale for using urinary NEP activity as an index of the enzyme in the kidney.
Other physiological fluids such as cerebrospinal fluid and amniotic fluid [23] and the synovial fluid [28) contain detectable amounts of a soluble form of NEP. In the synovial fluid, NEP activity seems to increase during inflammatory processes [28] . It is noteworthy that in urine, as in other physiological fluids, the nature of the soluble NEP is not clear. In particular, it is not known whether the soluble peptidase is a secreted mature form without the anchoring transmembrane domain or is released by a shedding process as a consequence of cell turnover [18] . Our study has demonstrated for the first time that the activity of the peptidase in the urine and renal tissue may be modulated by chronic salt loading. Although the mechanism responsible for the latter phenomenon has not been established, our finding suggests that the renal activity of the peptidase may be regulated by sodium balance or factor(s) related to it. Moreover, the finding that a similar increment in urine flow and in sodium excretion produced by acute i.v. saline loading was not associated with any detectable change in urinary NEP activity suggests that the elevated enzyme activity is not related to the increase in urinary flow rate or sodium excretionperse. Rather, the finding that enzyme activity increased both in proximal tubular segments and in the urine during salt loading may imply that this phenomenon is an adaptive response to the high dietary sodium intake. This, in turn, may be due to regulatory action at the transcription level, the degree of protein turnover, or a combination of both.
In several systems it has been shown that NEP is synthesized as an 85-kDa non-glycosylated precursor with subsequent N-glycosylation in the endoplasmic reticulum before the final processing in the Golgi apparatus results in the active 93-kDa protein [29] . This biosynthetic process takes about 90 minutes, which may explain why urinary NEP activity was augmented only during chronic salt loading, but not in the short-term saline-infusion studies.
It is well established that an increase in salt intake is associated with activation of endogenous natriuretic systems as part of a homeostatic response which prevents excessive accumulation of salt in the body [30, 31] . The metabolic degradation of at least two such systems, that is, that of ANP and bradykinin, is critically dependent on NEP activity. It is possible that the increase in NEP in the kidney is an adaptive response aimed at balancing the enhanced activity of the natriuretic systems. Thus, the resetting of both hormone action and its metabolic clearance to a higher level of operation contributes to the efficient performance of such a control system. This would allow the prompt increase of sodium excretion during salt loading and, at the same time, may prevent excessive salt wasting, by rapidly inactivating the hormone when required.
The mechanism(s) modulating such an adaptive increase in enzyme activity are, as yet, unknown. Further investigations will be required to examine whether this phenomenon is secondary to the activation of the natriuretic hormonal systems or if, alternatively, the increases in both endogenous natriuretic agents and renal NEP activity are triggered independently by the increase in salt intake. In summary, our findings suggest that the activity of NEP in the kidney is modulated by salt loading. Moreover, this alteration may be detected by measuring urinary NEP, which may serve as a reliable index of the renal activity of the enzyme.
